|
|
||||||||||||||
|
|
|||||||||||||||
RESEARCH PAPER |
1 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada
2 Direction de santé publique de Montréal-Centre, Montréal, Québec, Canada
3 Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA
4 Centre for Addictions and Mental Health, Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
Correspondence to:
Dr Jennifer OLoughlin
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, 1020 Pine Avenue West, Montréal, Québec, Canada H3A 1A3; jennifer.oloughlin{at}mcgill.ca
Objective: Case control studies in adults suggest that defective alleles in the gene that codes for the hepatic cytochrome P450 2A6 (CYP2A6) protect against nicotine dependence (ND) and higher levels of cigarette consumption. These two hypotheses were tested in young adolescents.
Design: Self reports of tobacco use and ND symptoms were collected every 34 months in a prospective study of 1293 grade 7 students from a convenience sample of 10 schools.
Subjects: 281 smokers with genetic data were analysed; those who were not already tobacco dependent and who had inhaled (n = 228) were followed 29.9 months on average, until they became dependent or were censored.
Main outcome measures: The association between metabolic activity, represented by CYP2A6 genotype, and conversion to dependence was analysed using Coxs proportional hazards model.
Results: During follow up 67 subjects (29.4%) became dependent. Relative to CYP2A6*1/*1, having 12 copies of the inactive CYP2A6*2 or *4 variant was a strong risk factor for developing dependence (hazard ratio 2.8, 95% confidence 1.3 to 6.3). Subjects with 12 partially inactive CYP2A6*9 or *12 variants were not at increased risk. Mean past-week cigarette consumption at the end of follow up (controlling for age, sex, and number of months since first inhalation) among dependent subjects was 29.1 among normal inactivators, compared to 17.2, and 12.7 among slower (12 copies of *9 or *12), and slowest (12 copies of *2 or *4) inactivators, respectively (p = 0.09).
Conclusion: Adolescents with 12 copies of CYP2A6*2 or *4 are at substantially increased risk of becoming dependent but smoke less once dependent. Genetic risk for ND may need to be considered in the conceptualisation of tobacco control programmes for adolescents.
Keywords: CYP2A6; adolescent; nicotine dependence; smoking onset; tobacco use
This article has been cited by other articles:
![]() |
R. Rende and C. Slomkowski Incorporating the Family as a Critical Context in Genetic Studies of Children: Implications for Understanding Pathways to Risky Behavior and Substance Use J. Pediatr. Psychol., June 12, 2008; (2008) jsn053v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Ho and R. F. Tyndale Role of CYP2A6 Genetic Variation on Smoking Behaviors and Clinical Implications ASCO Educational Book, January 1, 2008; 2008(1): 74 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kandel, M.-C. Hu, C. Schaffran, J. R. Udry, and N. L. Benowitz Urine Nicotine Metabolites and Smoking Behavior in a Multiracial/Multiethnic National Sample of Young Adults Am. J. Epidemiol., April 15, 2007; 165(8): 901 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Audrain-McGovern, N. A. Koudsi, D. Rodriguez, E. P. Wileyto, P. G. Shields, and R. F. Tyndale The Role of CYP2A6 in the Emergence of Nicotine Dependence in Adolescents Pediatrics, January 1, 2007; 119(1): e264 - e274. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Malaiyandi, S. D. Goodz, E. M. Sellers, and R. F. Tyndale CYP2A6 Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers during Ad libitum Smoking. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1812 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Karp, J O'Loughlin, J Hanley, R F Tyndale, and G Paradis Risk factors for tobacco dependence in adolescent smokers Tob. Control, June 1, 2006; 15(3): 199 - 204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |